Since the seminal reports by the groups of Glorius and Bode in 2004^[@R1]^ much attention has been paid to develop novel N-heterocyclic carbene (NHC)-catalyzed cyclization/annulation methods.^[@R2]^ Especially NHC-based α,β-unsaturated acylazolium intermediates turned out to be excellent electrophiles,^[@R3]^ which could undergo stepwise Michael--acylation or sigmatropic rearrangement--acylation reactions with a variety of dinucleophiles such as 1,3-diketones,^[@R4]^ enamines,^[@R5]^ naphthols,^[@R6]^ or enolizable aldehydes.^[@R7]^ Recently, the Ye group reported a \[3+3\] cyclocondensation of bromoenals with ketimines in the asymmetric synthesis of dihydropyridinones.^[@R8]^ Very recently our group developed NHC-catalyzed enantioselective annulations of indolin-3-ones with 2-bromoenals to form dihydropyranoindolones.^[@R9]^ In view of the importance of such heterocycles as potentially bioactive compounds the research for further suitable nucleophiles in these annulation protocols is highly desirable.

The dihydro-1*H*-benzothiazolopyridine core is present in various biologically active natural products and has found widespread applications in numerous pharmaceuticals, such as antitumor^[@R10]^ and antibacterial drugs.^[@R11]^ However, only a few asymmetric syntheses have been investigated. In 2013 Smith and co-workers reported an asymmetric annulation of benzothiazolyl ketones with α,β-unsaturated anhydrides catalyzed by the isothiourea HBTM 2.1 ([Scheme 1, a](#F2){ref-type="fig"}).^[@R12]^ Very recently, we reported a Mannich--lactamization domino reaction of *N*-(benzothiazolyl)imines with 2-chloroaldehydes for the synthesis of benzothiazolo-pyrimidinones ([Scheme 1, b](#F2){ref-type="fig"})^[@R13]^, followed by an extended work on 1-azadiene-Diels--Alder reactions of styrylbenzo\[*d*\]thiazoles with α-chloroaldehydes ([Scheme 1, c](#F2){ref-type="fig"}).^[@R14]^ Herein, we report the asymmetric synthesis of dihydro-1*H*-benzothiazolopyridine-2-ones via the formal \[3+3\] annulation reaction of 2-bromoenals with 2-substituted benzo\[*d*\]thiazoles ([Scheme 1, d](#F2){ref-type="fig"}).

Initially, we performed the model reaction of 2-(benzothiazol-2-yl) ethyl acetate (**1a**) with 2-bromocinnamaldehyde (**2a**) at room temperature in toluene in the presence of *N,N*-diisopropyl ethylamine (DIPEA) and 10 mol% of the triazolium precatalyst **A**, which proceeded smoothly and gave a 45% yield of the product **3a** ([Table 1](#T1){ref-type="table"}, entry 1). Chiral triazolium salts **B**--**F** were also screened and a good yield of 83% and an enantiomeric excess of 80% were obtained with the triazolium salt **C** ([Table 1](#T1){ref-type="table"}, entry 3). Next we screened a series of bases, however, organic bases such as DABCO, TMEDA, TBD, or DBU and inorganic bases such as K~3~PO~4~ and K~2~CO~3~ gave inferior results ([Table 1](#T1){ref-type="table"}, entries 7--12). We then tested a series of solvents in the presence of precatalyst **C** and DIPEA at room temperature. Unfortunately, no improvement was obtained ([Table 1](#T1){ref-type="table"}, entries 13--17), even with the mixed solvents of toluene--THF ([Table 1](#T1){ref-type="table"}, entry 18) and toluene--MeCN ([Table 1](#T1){ref-type="table"}, entry 19). Inspired by recent reports on the NHC--Lewis acid strategy^[@R15]^ we examined some Lewis acids as additives in our protocol. The strong Lewis acid Sc(OTf)~3~ lowered the reactivity and enantioselectivity ([Table 1](#T1){ref-type="table"}, entry 20), and the use of the weak Lewis acid LiCl even inversed the asymmetric induction ([Table 1](#T1){ref-type="table"}, entry 21). Finally, we lowered the reaction temperature, however, no further improvement on enantioselectivity was obtained at 5 °C ([Table 1](#T1){ref-type="table"}, entry 22) and −20 °C ([Table 1](#T1){ref-type="table"}, entry 23).

We then amplified the scale of the model reaction to 0.5 mmol, which afforded **3a** in 77% yield and 65% ee.^[@R16]^ Fortunately, a single recrystallization allowed to access the virtually enantiopure product (99% ee, [Table 2](#T2){ref-type="table"}, entry 1). Next we investigated the substrate scope of this protocol by variation of the 2-substituted benzo\[*d*\]thiazole component **1**. A methyl ester and a cyano group as R^1^ gave the desired adducts in good to excellent yields and moderate ee values ([Table 2](#T2){ref-type="table"}, entries 2 and 3). Gratifyingly, 2-(benzoxazol-2-yl)acetonitrile underwent the transformation smoothly and furnished the desired \[3+3\] annulation product in moderate yield and ee ([Table 2](#T2){ref-type="table"}, entry 4). Furthermore, various electron-donating and electron-withdrawing groups, as well as *ortho* substituents attached to the aryl group of the bromoenals (R^2^) were well tolerated, leading to the desired products in good yields and moderate enantiomeric excess ([Table 2](#T2){ref-type="table"}, entries 5--10). Notably, several products could be obtained as virtually enantiopure compounds (99% ee) after a single recrystallization. Additionally, a heterocyclic 2-furyl substituent R^2^ can be used resulting in a 77% yield and 58% ee ([Table 2](#T2){ref-type="table"}, entry 11).

The absolute configuration was unambiguously determined to be *S* by X-ray crystal-structure analysis of the methyl acetate **3b** ([Figure 1](#F1){ref-type="fig"}).^[@R17]^

A plausible reaction mechanism for this NHC-catalyzed formal \[3+3\] annulation is shown in [Scheme 2](#F3){ref-type="fig"}. The addition of the NHC **C′** to the 2-bromoenal **2** leads to the Breslow intermediate **I**, also drawn as its mesomeric zwitterionic form. After tautomerization to **II**, the subsequent loss of bromide generates the α,β-unsaturated acylazolium key intermediate **III**. The base-mediated Michael addition of the benzothiazolyl ethyl acetates **1** affords the adduct **IV**, followed by proton transfer and lactamization via **V** to furnish the final product **3** and to return the NHC catalyst.

In summary, we have developed a novel NHC-catalyzed asymmetric annulation of 2-(benzothiazol-2-yl) acetates with 2-bromoenals. The protocol tolerates quite a range of substrates including a benzoxazolyl acetonitrile and give rise to the corresponding dihydro-1*H*-benzothiazolopyridinones in moderate to very good yields and medium ee values. However, in several cases virtually enantiopure products (99% ee) could be obtained via a single recrystallization.
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###### 

Optimization of the Reaction Conditions^[a](#TFN1){ref-type="table-fn"}^

  ------------------------------------- ------- ---------------------- -------------------------------------- ---------------- ------- -----
  1                                     **A**   toluene                DIPEA                                  --               45      --
  2                                     **B**   toluene                DIPEA                                  --               29      −26
  3                                     **C**   toluene                DIPEA                                  --               83      80
  4                                     **D**   toluene                DIPEA                                  --               61      75
  5                                     **E**   toluene                DIPEA                                  --               71      1
  6                                     **F**   toluene                DIPEA                                  --               n.r.    --
  7                                     **C**   toluene                DABCO                                  --               66      79
  8                                     **C**   toluene                TMEDA                                  --               86      68
  9                                     **C**   toluene                TBD^[d](#TFN4){ref-type="table-fn"}^   --               trace   --
  10                                    **C**   toluene                DBU                                    --               23      −22
  11                                    **C**   toluene                K~3~PO~4~                              --               20      63
  12                                    **C**   toluene                K~2~CO~3~                              --               9       68
  13                                    **C**   MeCN                   DIPEA                                  --               80      73
  14                                    **C**   CH~2~Cl~2~             DIPEA                                  --               80      32
  15                                    **C**   THF                    DIPEA                                  --               26      41
  16                                    **C**   MTBE                   DIPEA                                  --               57      73
  17                                    **C**   mesitylene             DIPEA                                  --               46      82
  18                                    **C**   toluene--THF (10:1)    DIPEA                                  --               70      79
  19                                    **C**   toluene--MeCN (10:1)   DIPEA                                  --               82      69
  20                                    **C**   toluene                DIPEA                                  Sc(OTf)~3~       29      66
  21                                    **C**   toluene                DIPEA                                  LiCl (1 equiv)   29      −18
  22^[e](#TFN5){ref-type="table-fn"}^   **C**   toluene                DIPEA                                  --               76      76
  23^[f](#TFN6){ref-type="table-fn"}^   **C**   toluene                DIPEA                                  --               76      77
  ------------------------------------- ------- ---------------------- -------------------------------------- ---------------- ------- -----

Reaction conditions: **1a** (0.2 mmol), **2a** (0.3 mmol), precatalyst (0.02 mmol), base (0.24 mmol), solvent (2 mL), r.t., under argon, 20 h.

Yield of isolated product **3a** after column chromatography.

The ee was determined by HPLC on a chiral stationary phase.

TBD = 1,5,7-triazabicyclo\[4.4.0\]dec-5-ene.

Performed at 5 °C for 4 d.

Performed at −20 °C for 4 d.

###### 

Substrate Scope^[a](#TFN7){ref-type="table-fn"}^

  ---- -------- --------- -------------------- --- ---- ---------
  1    **3a**   CO~2~Et   Ph                   S   77   65 (99)
  2    **3b**   CO~2~Me   Ph                   S   91   64
  3    **3c**   CN        Ph                   S   74   32
  4    **3d**   CN        Ph                   O   43   55
  5    **3e**   CO~2~Et   4-MeC~6~H~4~         S   64   68
  6    **3f**   CO~2~Et   4-MeOC~6~H~4~        S   69   62 (99)
  7    **3g**   CO~2~Et   2-MeO-5-BrC~6~H~3~   S   80   65 (92)
  8    **3h**   CO~2~Et   2-MeOC~6~H~4~        S   86   66 (99)
  9    **3i**   CO~2~Et   4-ClC~6~H~4~         S   72   73
  10   **3j**   CO~2~Et   4-BrC~6~H~4~         S   83   70 (99)
  11   **3k**   CO~2~Et   2-furyl              S   77   58
  ---- -------- --------- -------------------- --- ---- ---------

Reaction conditions: **1** (0.5 mmol), **2** (0.75 mmol), precatalyst **C** (0.05 mmol), DIPEA (0.6 mmol), toluene (5 mL), r.t., under argon, 20 h.

Yield of isolated product **3** after column chromatography.

The ee was determined by HPLC on a chiral stationary phase.

The value in parentheses refers to the ee after recrystallization.
